A Multi-part, Multi-center PLATform Study to Assess the Efficacy, Safety, Tolerability and Pharmacokinetics of Anti-malarial Agents Administered as Monotherapy and/or Combination Therapy IN Participants With Uncomplicated Plasmodium Falciparum Malaria
Latest Information Update: 26 Nov 2025
At a glance
- Drugs INE 963 (Primary)
- Indications Falciparum malaria
- Focus Therapeutic Use
- Acronyms PLATINUM
- Sponsors Novartis; Novartis Pharmaceuticals
Most Recent Events
- 26 Nov 2025 New trial record